ENDRA Life Sciences
NDRA | NASDAQ
$4.42
+$0.01 (+0.23%)
At close: Nov 16, 2026, 4:00 PM ET
$4.42
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:11 PM ET
+0.23%
(1D)No price chart data available for 1D timeframe.
Rating
29
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #836/1021 (Top 82%)
Key Statistics
Market Data
Market Cap $6.63M
1D Range
4.32 4.46
52W Range
3.26 6.69
Valuation (TTM)
PE -0.69
PB 1.05
EV/EBITDA -0.72
Valuation (NTM)
Forward PE N/A
Forward PEG 0.02
Price Target $25.00
Cash Flow
FCF Yield -118.3%
SBC Adj. FCF Yield -137.5%
SBC Impact -16.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -4.6% |
100.0%
FCF 3Y | 5Y 7.9% |
15.2%
Returns
ROA -74.5%
ROE -224.8%
ROIC -91.2%
Financial Health
Net Cash
$1.74M
Current Ratio 7.10
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operate...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 10
IPO Date Jun 30, 2017
Website www.endrainc.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$25.00
Upside
+465.61%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NDRA